Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel H Greig

Showing results (221-230 of 332) with videos related to

Pageof 34
Sort By:
Scientific Reports|November 22, 2019
Pharmacokinetics of Exenatide in nonhuman primates following its administration in the form of sustained-release PT320 and BydureonYazhou Li, Kelli L Vaughan, David Tweedie, et al.
Journal of Neuroscience Methods|February 13, 2016
Mild traumatic brain injury-induced hippocampal gene expressions: The identification of target cellular processes for drug developmentDavid Tweedie, Lital Rachmany, Dong Seok Kim, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 13, 2006
Identification of novel small molecule inhibitors of amyloid precursor protein synthesis as a route to lower Alzheimer's disease amyloid-beta peptideTada Utsuki, Qian-Sheng Yu, Diane Davidson, et al.
Biomolecules|May 27, 2023
A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative DisordersKatherine O Kopp, Margaret E Greer, Elliot J Glotfelty, et al.
Plos One|April 5, 2013
Age-dependent neuroplasticity mechanisms in Alzheimer Tg2576 mice following modulation of brain amyloid-β levelsAnna M Lilja, Jennie Röjdner, Tamanna Mustafiz, et al.
Brain : a Journal of Neurology|March 24, 2017
Insulin resistance and exendin-4 treatment for multiple system atrophyFares Bassil, Marie-Hélène Canron, Anne Vital, et al.
Current Alzheimer Research|May 10, 2017
Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future PerspectiveJaved Ahmad, Sohail Akhter, Md Rizwanullah, et al.
Annals of Neurology|October 29, 2002
p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonismWenzhen Duan, Xiaoxiang Zhu, Bruce Ladenheim, et al.
International Journal of Molecular Sciences|January 10, 2026
Correction: Batsaikhan et al. Post-Injury Neuroprotective Effects of the Thalidomide Analog 3,6'-Dithiothalidomide on Traumatic Brain Injury. <i>Int. J. Mol. Sci.</i> 2019, <i>20</i>, 502Buyandelger Batsaikhan, Jing-Ya Wang, Michael T Scerba, et al.
Current Neuropharmacology|June 9, 2026
Exploring the Cellular and Molecular Mechanisms Underlying Alzheimer's Disease Utilizing Cerebral Organoids Derived from Patient-specific Induced Pluripotent Stem Cells (iPSCs): A Review with Implications for Surgical InterventionsHarpreet Singh, Bhuvnesh Kumar Singh, Anil Kumar, et al.
Pageof 34

Showing results (221-230 of 332) with videos related to

Sort By:
Pageof 34
Scientific Reports|November 22, 2019
Pharmacokinetics of Exenatide in nonhuman primates following its administration in the form of sustained-release PT320 and BydureonYazhou Li, Kelli L Vaughan, David Tweedie, et al.
Journal of Neuroscience Methods|February 13, 2016
Mild traumatic brain injury-induced hippocampal gene expressions: The identification of target cellular processes for drug developmentDavid Tweedie, Lital Rachmany, Dong Seok Kim, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 13, 2006
Identification of novel small molecule inhibitors of amyloid precursor protein synthesis as a route to lower Alzheimer's disease amyloid-beta peptideTada Utsuki, Qian-Sheng Yu, Diane Davidson, et al.
Biomolecules|May 27, 2023
A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative DisordersKatherine O Kopp, Margaret E Greer, Elliot J Glotfelty, et al.
Plos One|April 5, 2013
Age-dependent neuroplasticity mechanisms in Alzheimer Tg2576 mice following modulation of brain amyloid-β levelsAnna M Lilja, Jennie Röjdner, Tamanna Mustafiz, et al.
Brain : a Journal of Neurology|March 24, 2017
Insulin resistance and exendin-4 treatment for multiple system atrophyFares Bassil, Marie-Hélène Canron, Anne Vital, et al.
Current Alzheimer Research|May 10, 2017
Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future PerspectiveJaved Ahmad, Sohail Akhter, Md Rizwanullah, et al.
Annals of Neurology|October 29, 2002
p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonismWenzhen Duan, Xiaoxiang Zhu, Bruce Ladenheim, et al.
International Journal of Molecular Sciences|January 10, 2026
Correction: Batsaikhan et al. Post-Injury Neuroprotective Effects of the Thalidomide Analog 3,6'-Dithiothalidomide on Traumatic Brain Injury. <i>Int. J. Mol. Sci.</i> 2019, <i>20</i>, 502Buyandelger Batsaikhan, Jing-Ya Wang, Michael T Scerba, et al.
Current Neuropharmacology|June 9, 2026
Exploring the Cellular and Molecular Mechanisms Underlying Alzheimer's Disease Utilizing Cerebral Organoids Derived from Patient-specific Induced Pluripotent Stem Cells (iPSCs): A Review with Implications for Surgical InterventionsHarpreet Singh, Bhuvnesh Kumar Singh, Anil Kumar, et al.
Pageof 34